Change in serum lipid profiles and glucose subsequent to changing from stavudine/lamivudine to zidovudine/lamivudine in non-nucleoside reverse transcriptase inhibitors based hostile to retroviral regimens in Southern Ethiopia . AJAHR [Internet]. 2015 Feb. 21 [cited 2026 Oct. 28];3(1):1-9. Available from: https://kevinpage.org/index.php/AJAHR/article/view/16